medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Number 4

<< Back Next >>

Ann Hepatol 2012; 11 (4)

Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation

Chuan L, Tian-Fu W, Lu-Nan Y, Bo L, Jia-Ying Y, Ming-Qing X, Wen-Tao W, Yong-Gang W

Language: English
References: 29
Page: 471-477
PDF size: 104.57 Kb.


ABSTRACT

Background. Living donor liver transplantation (LDLT) for patients with high model for end-stage liver disease (MELD) scores is controversial due to its poor outcome. However, there is little information regarding which factor would negatively impact the outcome of patients with high MELD scores. The aim of this study was to identify factors associated with the in-hospital mortality of patients with high MELD scores after LDLT. Material and methods. All patients with an MELD scores ≤ 20 who received LDLT from 2005 to 2011 were recruited for the present study. Pre- and intra-operative variables were retrospectively and statistically analyzed. Results. A total of 61 patients were included in the current study. The overall 3-month survival rate was 82% for patients with high MELD scores. Preoperative renal dysfunction, hyponatremia, starting albumin level ‹ 2.8 g/dL, preoperative renal replacement for severe renal failure, anhepatic period › 100 minutes and intraoperative red blood cell (RBC) transfusion ≥ 10 units were identified as potential risk factors by univariate analysis. However, only hyponatremia, preoperative dialysis and massive RBC transfusion were independent risk factors in a multivariate analysis. The 3-month survival rates of patients with two or more independent risk factors and patients with none or one risk factor were 91 and 25%, respectively. A significant difference was observed (P ‹ 0.001). Conclusion. Hyponatremia, preoperative dialysis and massive RBC transfusion were related to poor outcome for sicker patients. Patients with two or more of the above-mentioned risk factors and high MELD scores may exhibit extremely poor short-term survival.


REFERENCES

  1. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol 2010; 54: 1297-306.

  2. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-4.

  3. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805.

  4. Nadalin S, Schaffer R, Fruehauf N. Split-liver transplantation in the high-MELD adult patient: are we being too cautious? Transpl Int 2009; 22: 702-6.

  5. Selzner M, Kashfi A, Cattral MS, et al. Live donor liver transplantation in high MELD score recipients. Ann Surg 2010; 251: 153-7.

  6. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41: 1282-9.

  7. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien- Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96.

  8. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992; 111: 518-26.

  9. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004: 240: 205-13.

  10. Li C, Wen TF, Yan LN, et al. Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2011; 10: 248-53.

  11. Hackworth WA, Heuman DM, Sanyal AJ, et al. Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int 2009; 29: 1071-7.

  12. Dawwas MF, Lewsey JD, Watson CJ, Gimson AE. The impact of serum potassium concentration on mortality after liver transplantation: a cohort multicenter study. Transplantation 2009; 88: 402-10.

  13. Kaido T, Egawa H, Tsuji H, Ashihara E, Maekawa T, Uemoto S. In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl 2009; 15: 1420-5.

  14. Li C, Mi K, Wen TF, et al. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One 2011; 6: e27366.

  15. Earl TM, Chari RS. Which types of graft to use in patients with acute liver failure? (A) Auxiliary liver transplant (B) Living donor liver transplantation (C) The whole liver. (C) I take the whole liver only. J Hepatol 2007; 46: 578-82.

  16. Benson AB, Burton JR, Austin GL, et al. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011; 17: 149-58.

  17. Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320-7.

  18. Hendriks HG, van der Meer J, de Wolf JT, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 2005; 17: 673-9.

  19. Kim J, Yi NJ, Shin WY, Kim T, Lee KU, Suh KS. Platelet transfusion can be related to liver regeneration after living donor liver transplantation. World J Surg 2010; 34: 1052-8.

  20. Tomimaru Y, Wada H, Marubashi S, et al. Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol 2010; 16: 5603-10.

  21. Park I, Moon E, Hwang JA, et al. Does hepatorenal syndrome affect the result of liver transplantation? Clinical observations. Transplant Proc 2010; 42: 2563-6.

  22. Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 2004; 78: 1351-5.

  23. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-85.

  24. Dellon ES, Galanko JA, Medapalli RK, Russo MW. Impact of dialysis and older age on survival after liver transplantation. Am J Transplant 2006; 6: 2183-90.

  25. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.

  26. Carey RG, Bucuvalas JC, Balistreri WF, Nick TG, Ryckman FR, Yazigi N. Hyponatremia increases mortality in pediatric patients listed for liver transplantation. Pediatr Transplant 2010; 14: 115-20.

  27. Balderramo D, Prieto J, Cardenas A, Navasa M. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation. Transpl Int 2011; 24: 812-9.

  28. Emiroglu R, Yilmaz U, Coskun M, Karakayali H, Haberal M. Higher graft-to-host ratio may decrease posttransplant mortality in patients with a high MELD score. Transplant Proc 2007; 39: 1164-5.

  29. Yi NJ, Suh KS, Lee HW, et al. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl 2009; 15: 496-503.




2020     |     www.medigraphic.com